Laboratory Corporation of Amerc Holdings
General ticker "LH" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $19.7B
Laboratory Corporation of Amerc Holdings follows the US Stock Market performance with the rate: 32.2%.
Estimated limits based on current volatility of 0.9%: low 225.75$, high 229.72$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-11-26, amount 0.72$ (Y1.25%)
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [207.56$, 285.96$]
- 2024-12-30 to 2025-12-30 estimated range: [245.49$, 329.54$]
Financial Metrics affecting the LH estimates:
- Positive: Non-GAAP EPS, $ of 13.92 > 2.29
- Positive: 1.03 < Operating profit margin, % of 5.97
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 2.45
- Negative: Investing cash flow per share, $ of -13.45 <= -3.48
- Negative: Inventory ratio change, % of 1.36 > 1.08
- Negative: Industry earnings per price (median), % of 1.35 <= 4.38
Short-term LH quotes
Long-term LH plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $13,136.10MM | $11,863.90MM | $12,161.60MM |
Operating Expenses | $10,087.50MM | $10,427.40MM | $11,436.00MM |
Operating Income | $3,048.60MM | $1,436.50MM | $725.60MM |
Non-Operating Income | $-161.00MM | $-199.10MM | $-156.70MM |
Interest Expense | $212.10MM | $180.30MM | $199.60MM |
Income(Loss) | $2,887.60MM | $1,237.40MM | $568.90MM |
Taxes | $690.00MM | $233.90MM | $188.50MM |
Other Income(Loss) | $181.90MM | $277.10MM | $38.80MM |
Profit(Loss) | $2,379.50MM | $1,280.60MM | $419.20MM |
Stockholders Equity | $10,273.40MM | $10,096.60MM | $7,875.00MM |
Inventory | $401.40MM | $470.60MM | $474.60MM |
Assets | $20,385.40MM | $20,155.10MM | $16,725.10MM |
Operating Cash Flow | $3,109.60MM | $1,955.90MM | $1,327.70MM |
Capital expenditure | $460.40MM | $481.90MM | $453.60MM |
Investing Cash Flow | $-884.60MM | $-1,652.20MM | $-1,171.50MM |
Financing Cash Flow | $-2,065.80MM | $-1,322.20MM | $-59.30MM |
Earnings Per Share* | $24.58 | $14.04 | $4.80 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.